Opportunity ID: 320894

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-19-059
Funding Opportunity Title: Limited Competition: Pediatric Brain Tumor Consortium (UM1 Clinical Trials Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.395 — Cancer Treatment Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 23, 2019
Last Updated Date: Sep 23, 2019
Original Closing Date for Applications: Nov 13, 2019
Current Closing Date for Applications: Nov 13, 2019
Archive Date: Dec 19, 2019
Estimated Total Program Funding: $4,000,000
Award Ceiling: $3,300,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Member Sites as Foreign components are allowed only if they are Canadian institutions. See FOA for full eligibility details.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) is intended to continue support for the Pediatric Brain Tumor Consortium (PBTC). This Limited-Competition FOA solicits a single application from the current PBTC awardee. The PBTC was conceived as a dedicated clinical trials organization able to translate innovative therapies from the laboratory to early phase clinical testing so that treatment for primary brain tumors in children can be improved. The importance of the PBTC is highlighted by the continuing high mortality rate among some common brain tumors occurring in children [e.g., diffuse intrinsic pontine gliomas (DIPG), malignant supratentorial gliomas, and biologically high-risk medulloblastomas and ependymomas] and the functional impediments apparent in a large proportion of children surviving current therapies. The PBTC is designed to fill a unique niche in the NIH pediatric brain tumor research portfolio through its ability to translate multiple innovative therapies from the laboratory to early phase clinical testing.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-059.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E FORMS-E PKG00255318 Oct 13, 2019 Nov 13, 2019 View

Package 1

Mandatory forms

320894 RR_SF424_2_0-2.0.pdf

320894 PHS398_CoverPageSupplement_4_0-4.0.pdf

320894 RR_OtherProjectInfo_1_4-1.4.pdf

320894 PerformanceSite_2_0-2.0.pdf

320894 RR_KeyPersonExpanded_2_0-2.0.pdf

320894 RR_Budget_1_4-1.4.pdf

320894 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

320894 RR_SubawardBudget30_1_4-1.4.pdf

320894 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T09:20:59-05:00

Share This Post, Choose Your Platform!

About the Author: